The approval follows the December 2024 priority review designation for this perioperative immunotherapy regimen for patients fighting muscle-invasive bladder cancer (MIBC).
AstraZeneca has secured another expansion of its Imfinzi for use in cancer patients before and after surgery. | Imfinzi is ...
Learn the 7 vital bladder cancer warning signs that require immediate medical attention, including subtle early symptoms many ...
A noninvasive urinary DNA methylation test demonstrated high sensitivity for detecting high-grade or invasive bladder cancer. A urinary DNA methylation test displayed superior sensitivity for ...
While upper-tract transitional cell ... Bladder cancer occurs in 15 50% of patients following upper-tract TCC, underscoring the necessity for regular postoperative interval cystoscopy and urinary ...
releasing mitomycin to target any remaining cancer cells. Because the mitomycin is gel-based, it remains in contact with the upper urinary tract longer, increasing its effectiveness. After ...
Quantitative imaging biomarkers (QIBs) derived from multiparametric MRI (mpMRI) and radiomics offer superior treatment assessment for bladder cancer compared to RECIST ... and computed tomography (CT) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback